228 related articles for article (PubMed ID: 15177278)
21. Expression of the non-glycosylated kringle domain of tissue type plasminogen activator in Pichia and its anti-endothelial cell activity.
Lee SB; Oh HK; Kim HK; Joe YA
Protein Expr Purif; 2006 Nov; 50(1):1-8. PubMed ID: 16854593
[TBL] [Abstract][Full Text] [Related]
22. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
23. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
[TBL] [Abstract][Full Text] [Related]
24. Angiostatin induces mitotic cell death of proliferating endothelial cells.
Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR
Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751
[TBL] [Abstract][Full Text] [Related]
25. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
26. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78.
Davidson DJ; Haskell C; Majest S; Kherzai A; Egan DA; Walter KA; Schneider A; Gubbins EF; Solomon L; Chen Z; Lesniewski R; Henkin J
Cancer Res; 2005 Jun; 65(11):4663-72. PubMed ID: 15930284
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of a recombinant anti-angiogenic kringle fragment expressed in Escherichia coli: Purification and characterization of a tri-kringle fragment from human apolipoprotein (a) (kringle IV (9)-kringle IV (10)-kringle V).
Kang KY; Kim SG; Kim WK; You HK; Kim YJ; Lee JH; Jung KH; Kim CW
Protein Expr Purif; 2006 Jan; 45(1):216-25. PubMed ID: 16260151
[TBL] [Abstract][Full Text] [Related]
28. Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor.
Zou Y; Chen Y; Jiang Y; Gao J; Gu J
Cancer Res; 2007 Aug; 67(15):7295-300. PubMed ID: 17671198
[TBL] [Abstract][Full Text] [Related]
29. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
[TBL] [Abstract][Full Text] [Related]
30. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris.
Zhou Y; Zheng Q; Gao J; Gu J
Biotechnol Lett; 2005 Feb; 27(3):167-71. PubMed ID: 15717125
[TBL] [Abstract][Full Text] [Related]
31. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
32. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization.
Cai W; Ma J; Li C; Yang Z; Yang X; Liu W; Liu Z; Li M; Gao G
J Cell Biochem; 2005 Dec; 96(6):1254-61. PubMed ID: 16167344
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
34. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
Su L; Xu X; Zhao H; Gu Q; Zou H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
[TBL] [Abstract][Full Text] [Related]
36. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
37. [Expression and biological activity of human angiogenesis inhibitor angiostatin in insect cells].
Xu XL; Liu GF; Huang DY
Ai Zheng; 2005 Sep; 24(9):1096-101. PubMed ID: 16159432
[TBL] [Abstract][Full Text] [Related]
38. p22 is a novel plasminogen fragment with antiangiogenic activity.
Kwon M; Yoon CS; Fitzpatrick S; Kassam G; Graham KS; Young MK; Waisman DM
Biochemistry; 2001 Nov; 40(44):13246-53. PubMed ID: 11683633
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of tumor growth by plasminogen-related protein-B.
Lewis VO; O'Reilly MS; Gehrmann M; Llinás M; Schaller J; Weissbach L
Anticancer Res; 2001; 21(4A):2287-91. PubMed ID: 11724284
[TBL] [Abstract][Full Text] [Related]
40. Expression of soluble, biologically active recombinant human endostatin in Escherichia coli.
Xu HM; Zhang GY; Ji XD; Cao L; Shu L; Hua ZC
Protein Expr Purif; 2005 Jun; 41(2):252-8. PubMed ID: 15866710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]